Herbert Chad Duber, MD, MPH, is an Adjunct Associate Professor of Health Metrics Sciences and an Associate Professor in the Department of Emergency Medicine at the University of Washington. He works clinically at the University of Washington Medical and Harborview Medical Centers in Seattle.
Dr. Duber’s work focuses on health systems development, program monitoring and evaluation, and determinants of health outcomes. He is also interested in health policy and social determinants of health among vulnerable populations. Dr. Duber has worked clinically, served in public health roles, and conducted research in numerous countries in Africa, Asia, Latin America, and the Caribbean. Dr. Duber is currently the principal investigator (PI) or co-PI on several ongoing studies. These include a cross-country assessment of Global Fund impact; an evaluation of a novel system of care for STEMI patients in India and China sponsored by the Medtronic Foundation; and a CDC-funded subcontract for a population-based HIV survey in Nigeria.
Dr. Duber received his BA in Biology from Pomona College, after which he was awarded a Fulbright Fellowship to study in Panama. He received his MD from the NYU School of Medicine and his MPH in International Health from the Harvard School of Public Health.
IHME was established at the University of Washington in Seattle in 2007. Its mission is to deliver to the world timely, relevant, and scientifically valid evidence to improve health policy and practice.
Johnson EK, Wojtesta MA, Crosby SW, et al. Varied health spending growth across US states was associated with income, price levels, and Medicaid expansion, 2000-19. Health Affairs. 1 August 2022. doi: 10.1377/hlthaff.2021.01834.
Woody Scott K, Liu A, Chen C, Kaldjian AS, Sabatini AK, Duber HC, Dieleman JL. Healthcare spending in U.S. emergency departments by health condition, 2006–2016. PLoS One. 27 October 2021. doi: 10.1371/journal.pone.0258182.
Carnahan E, Gurley N, Asiimwe G, et al. Lessons learned from implementing prospective, multicountry mixed-methods evaluations for Gavi and the Global Fund. Global Health: Science and Practice. 23 December 2020. doi: 10.9745/GHSP-D-20-00126.
Shelley, K.D., Kamya, C., Mpanya, G., et al. Partnership and Participation—A Social Network Analysis of the 2017 Global Fund Application Process in the Democratic Republic of the Congo and Uganda. Annals of Global Health, 86(1), p.140. DOI: http://doi.org/10.5334/aogh.2961.
Phillips DE, Ambrosio G, Batzel A, et al. Bringing a health systems modelling approach to complex evaluations: multicountry applications in HIV, TB and malaria. BMJ Global Health. 2020;5:e002441.
Bartlett ES, Flor LS, Medeiros DS, et al. Public knowledge of cardiovascular disease and response to acute cardiac events in three municipalities in Brazil. Open Heart 2020;7:e001322. doi: 10.1136/openhrt-2020-001322.
Flor LS, Wilson S, Bhatt P, et al. Community-based interventions for detection and management of diabetes and hypertension in underserved communities: a mixed-methods evaluation in Brazil, India, South Africa and the USA. BMJ Global Health. 15 April 2020. doi:10.1136/ bmjgh-2019-001959.
Dieleman JL, Cao J, Chapin A, Chen C, Li Z, Liu A, Horst C, Kaldjian A, Matyasz T, Scott KW, Bui AL, Campbell M, Duber HC, Dunn AC, Flaxman AD, Fitzmaurice C, Naghavi M, Sadat N, Shieh P, Squires E, Yeung K, Murray CJL. US Health Care Spending by Payer and Health Condition, 1996–2016. JAMA. 3 March 2020. doi:10.1001/jama.2020.0734.
GBD 2017 HIV Collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. The Lancet HIV. 14 August 2019. doi:10.1016/S2352-3018(19)30196-1.
Duber HC, Hartford EA, Schaefer AM, Johanns CK, Colombara DV, Iriarte E, Palmisano EB, Rios-Zertuche D, Hernandez-Prado B, Mokdad AH. Appropriate and timely antibiotic administration for neonatal sepsis in Mesoamérica. BMJ Global Health. 2018;3:e000650. doi: 10.1136/bmjgh-2017-000650.
Wollum A, Gabert R, McNellan CR, Daly JM, Reddy P, Bhatt P, Bryant M, Colombara DV, Naidoo P, Ngongo B, Nyembezi A, Petersen Z, Pillips B, Wilson S, Gakidou E, Duber HC. Identifying gaps in the continuum of care for cardiovascular disease and diabetes in two communities in South Africa: Baseline findings from the HealthRise project. PLoS One. 14 March 2018. doi:10.1371/journal.pone.0192603.
Gabert R, Ng M, Sogarwal R, Bryant M, Deepu RV, McNellan CR, Mehra S, Phillips B, Reitsma M, Thomson B, Wilson S, Wollum A, Gakidou E, Duber HC. Identifying gaps in the continuum of care for hypertension and diabetes in two Indian communities. BMC Health Services Research. 27 December 2017. doi:10.1186/s12913-017-2796-9.
Duber HC, McNellan CR, Wollum A, et al. Public knowledge of cardiovascular disease and response to acute cardiac events in three cities in China and India. Heart 2018;104:67-72.
Wollum A, Dansereau E, Fullman N, Achan J, Bannon KA, Burstein R, Conner RO, DeCenso B, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Masters SH, Njuguna P, Okiro EA, Odeny TA, Roberts DA, Gakidou E, Duber HC. The effect of facility-based antiretroviral therapy programs on outpatient services in Kenya and Uganda. BMC Health Services Research. 2017 Aug 16. doi: 10.1186/s12913-017-2512-9.
Carlson S, Duber HC, Achan J, Ikilezi G, Mokdad AH, Stergachis A, Wollum A, Bukhman G, Roth GA. Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa. Heart. 2017 May 10. doi: 10.1136/heartjnl-2016-310913.
Bui AL, Dieleman JL, Hamavid H, Birger M, Chapin A, Duber HC, Horst C, Reynolds A, Squires E, Chung PJ, Murray CJL. Spending on children’s personal health care in the United States, 1996–2013. JAMA Pediatrics. 2016 Dec 27. doi:10.1001/jamapediatrics.2016.4086.
Di Giorgio L, Moses MW, Fullman N, et al. The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia. BMC Medicine. 2016 20 July. doi: 10.1186/s12916-016-0653-z.
Dandona R, Rewari BB, Kumar GA, Tanwar S,Kumar SGP, Vishnumolakala VS, Duber HC, Gakidou E, Dandona L. Survival outcomes for first-line antiretroviral therapy in India’s ART program. BMC Infectious Diseases. 2016 May 18. DOI: 10.1186/s12879-016-1887-2
Duber HC, Roberts DA, Ikilezi G, Fullman N, Gasasira A, Gakidou G, Haakenstad A, Levine AJ, Achan J. Evaluating facility-based antiretroviral therapy program effectiveness: a pilot study comparing viral load suppression and retention rates. Tropical Medicine & Hygiene. 2016 March 21. doi: 10.1111/tmi.12694.
Odeny TA, DeCenso B, Dansereau E, Gasasira A, Kisia C, Njuguna P, Haakenstad A, Gakidou E, Duber HD. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya. Journal of the International AIDS Society. 2015 Oct 26; 18:20019. doi: 10.7448/IAS.18.1.20019.
Murray CJL, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet. 2015 Aug 27. doi: 10.1016/S0140-6736(15)61340-X.
Dansereau E, Gakidou E, Ng M, Achan J, Burstein R, DeCenso B, Gasasira A, Ikilezi G, Kisia C, Masters SH, Njuguna P, Odeny TA, Okiro EA, Roberts DA, Duber HC. Trends and determinants of antiretroviral therapy patient monitoring practices in Kenya and Uganda. PLOS One. 2015 Aug 14. doi: 10.1371/journal.pone.0135653.
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2015 June 8. doi: 10.1016/S0140-6736(15)60692-4.
Duber HC, Dansereau E, Masters SH, Achan J, Burstein R, DeCenso B, Gasasira A, Ikilezi G, Kisia C, Masiye F, Njuguna P, Odeny T, Okiro E, Roberts DA, Gakidou E. Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia. PLOS One. 2015 March 25. doi: 10.1371/journal.pone.0120350.
Naghavi M, Wang H, Lozano R, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014 Dec 17. doi: 10.1016/S0140-6736(14)61682-2.
Murray CJL, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014 July 23. doi: 10.1016/S0140-6736(14)60844-8.
Murray CJL, Abraham J, Ali MK, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors [published online July 10, 2013]. Journal of the American Medical Association. DOI: 10.1001/jama.2013.13805.
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012 Dec 13; 380: 2163–2196.
Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012 Dec 13; 380: 2095–2128.